Tamoxifen is available in a tablet (10 mg or 20 mg) or an oral solution (10 mg/5 mL). If administered as an oral solution, it is important to use the supplied dosing cup for adequate administration.

FDA-approved indication dosing is as follows:

- The American Society of Clinical Oncology (ASCO) guidelines for Adjuvant Endocrine Therapy of Hormone-Receptor Positive Breast Cancer recommends a dose of 20 mg daily for breast cancer prevention after completion of chemotherapy. The duration of endocrine therapy depends on the patient's menopausal status and can last 5 to 10 years.

- To treat metastatic breast cancer, 20 to 40 mg daily is recommended, although clinical benefit has not been shown for doses above 20 mg daily.

- Breast cancer prophylaxis dosing is 20 mg daily for five years; used on high-risk females.

- For ductal cancer in situ (DCIS), dosing is 20 mg daily by mouth for five years following breast cancer surgery and X-ray therapy to decrease the risk of invasive breast cancer.

Off-label dosing for some indications is:

- Mastalgia: 10 mg orally once daily for four months.

- Ovulation induction:Â  5 to 40 mg by mouth once daily for four days.

- Precocious puberty (ages 2 to 10): 20 mg orally daily for female patients with McCune-Albright syndrome.

There are no necessary dose adjustments in patients with renal impairment. Hepatic dosing remains undefined as of this writing.